Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

21 Aug 2014
Price Change (% chg)

$0.15 (+0.89%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for AXDX.O


Accelerate Diagnostics, Inc., formerly Accelr8 Technology Corporation, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company focuses on the development of a rapid diagnostic platform, the BACcel system, intended for... (more)
No analyst recommendations are available for AXDX.O.


Beta: 0.65
Market Cap (Mil.): $748.55
Shares Outstanding (Mil.): 44.58
Dividend: --
Yield (%): --


  AXDX.O Industry Sector
P/E (TTM): -- 39.72 34.30
EPS (TTM): -0.53 -- --
ROI: -41.67 7.11 18.12
ROE: -42.00 11.46 18.84
Search Stocks

Deals of the day- Mergers and acquisitions

March 6 - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Thursday:

06 Mar 2014

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks